Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 25,169 | 21,888 | 20,170 | 18,221 | 18,902 |
| Operating Income | -25,169 | -21,888 | -20,170 | -18,221 | -18,902 |
| Other Income | 2,168 | 2,736 | 2,784 | 2,951 | 3,144 |
| Pre-tax Income | -23,001 | -19,152 | -17,386 | -15,270 | -15,758 |
| Income Tax | -1 | 74 | -16,173 | N/A | -2 |
| Net Income Continuous | -23,000 | -19,226 | -1,213 | -15,270 | -15,756 |
| Net Income | $-23,000 | $-19,226 | $-1,213 | $-15,270 | $-15,756 |
| EPS Basic Total Ops | -0.45 | -0.37 | -0.02 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.45 | -0.37 | -0.02 | -0.30 | -0.30 |
| EPS Diluted Total Ops | -0.45 | -0.37 | -0.02 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.45 | -0.37 | -0.02 | -0.30 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.37 | -0.02 | N/A | N/A |
| EBITDA(a) | $-26,262 | $-22,752 | $-21,174 | $-19,487 | $-20,418 |